Organon Canada's operations are led by a diverse and
highly capable team of equally represented men and women, offering
a combination of relevant skills and experience, with a mission to
deliver impactful medicines and solutions for a healthier every day
for everyone, with a focus on women's health.
KIRKLAND, QC, Oct. 8, 2024
/CNW/ - Organon Canada, a subsidiary of Organon (NYSE: OGN), a
global healthcare company with a focus on women's health, today
announced updates to its Canadian leadership team with an
appointment and promotion.
Effective September 1, 2024,
Jeffrey Malawski has been appointed
to the position of Executive Director, Women's Health and
Established Brands. Previously, Mr. Malawski led the Corporate
Affairs and Community Engagement business unit at Organon Canada, a
position now held by Geneviève Gauthier whose promotion came into
effect on October 1, 2024. Prior to
this role, Ms. Gauthier served as Associate Director, Policy &
Access, and was instrumental in enhancing the company's corporate
presence at both federal and provincial levels.
"Geneviève and Jeff have played key roles since our company was
founded in 2021 and have helped to create Organon these last three
years. Their experience in the industry, expertise, and commitment
to Organon and women's health will help us achieve our company's
growth for the future," said Michael
Casia, President and Managing Director, Organon Canada.
"These leadership changes reflect our commitment to fostering a
high-performance culture while ensuring we continue to meet the
unmet health needs in women and the needs of our community.
Since the establishment of Organon Canada, Mr. Malawski has been
responsible for shaping and leading the development of policies,
pricing and contracting strategies, implementing the Patient
Support Programs, as well as overseeing the company's
communications activities. Throughout his tenure, Mr. Malawski has
played a pivotal role in the success of Organon Canada, its culture
and values, and in ensuring the success of his talented team.
"I look forward to continuing on my adventure at Organon Canada
and to contributing to the business unit's continued success to
help tackle the unmet health needs of women in Canada," said Jeffrey
Malawski. "I am proud of this talented team that drives
innovation and delivers impactful solutions to improve the health
and well-being of women. Collectively, we will build on our
successes and strive to make a lasting difference for girls, women
and their communities."
With over 20 years of experience in the healthcare industry,
Geneviève Gauthier brings a wealth of expertise in market research,
sales, marketing, public health, and policy and access. Recognized
for her strategic mindset, collaborative approach, and
authenticity, Ms. Gauthier will play a key role in overseeing the
company's communication and community engagement activities,
ensuring that its Patient Support Programs deliver exceptional
value to both patients and healthcare professionals, while also
helping to shape policy and contracting strategies that align with
the company's organizational objectives. In addition, she has been
an important driving force of the company's mission and social
impact strategy, notably through the meaningful relationship she
has cultivated with Le Chaînon, one of the largest resources for
women in difficulty in Québec, truly bringing our values to
life.
"I am honoured to be part of the Organon Canada leadership team
that launched our company's operations in Canada as a standalone entity. Building
awareness and fostering collaborations to address women's unmet
health needs and creating a stronger healthcare system for all will
be an extremely rewarding journey," said Geneviève Gauthier. "I
look forward to continuing our efforts working alongside
like-minded organizations and building on the solid strides our
team has made."
Organon Canada's operations are
led by a diverse and highly capable team of equally represented men
and women, offering a combination of relevant skills and
experience, with a mission to deliver impactful medicines and
solutions for a healthier every day for everyone, with a particular
focus on women. The company is also a proud recipient of the Women
in Governance Parity Certification.
Mr. Malawski holds an M.Sc. and B.Sc. in Health Administration
from both the University of Wisconsin
and University of Minnesota. Read Jeffrey Malawski's biography
here.
Ms. Gauthier holds an MBA in Marketing from Simon Fraser University and a Bachelor's degree in
Business Administration from Université du Québec à Montréal. You
can read her biography here.
About Organon
Organon is an independent global healthcare company with a
strategy to help improve the health of women throughout their
lives. Organon's diverse portfolio offers more than 60 medicines
and products in women's health, biosimilars, and a large franchise
of established medicines across a range of therapeutic areas. In
addition to Organon's current products, the company invests in
innovative solutions and research to drive future growth
opportunities in women's health and biosimilars. In addition,
Organon is pursuing opportunities to collaborate with
biopharmaceutical partners and innovators looking to commercialize
their products by leveraging its scale and agile presence in fast
growing international markets.
Organon has a global footprint with significant scale and
geographic reach, world-class commercial capabilities, and
approximately 10,000 employees with headquarters located in
Jersey City, New Jersey.
For more information, visit www.organon.ca and connect with us
on LinkedIn.
SOURCE Organon Canada Inc.